“…An amino acid-stimulated rise in ATP/ADP c was shown to be insufficient to close K ATP channels, ruling out a key aspect of the “canonical model” in which accelerated mitochondrial metabolism raises ATP/ADP c to close K ATP channels (Campbell and Newgard, 2021; Prentki et al, 2013; Thompson and Satin, 2021). In PKm1-deficient β-cells, amino acids increased ATP/ADP c similarly to control β-cells, but were unable to close K ATP channels.…”
Section: Discussionmentioning
confidence: 99%
“…Plasma membrane-localized pyruvate kinase (PK) plays a key role in this nutrient response by converting phosphoenolpyruvate (PEP) and ADP to pyruvate and ATP, locally raising the ATP/ADP ratio in the KATP channel microcompartment to depolarize the membrane and initiate insulin secretion 1 . This local mechanism of control obviates the "standard model" of β-cell fuel sensing in which mitochondrial oxidative phosphorylation raises the ATP/ADP ratio to close KATP channels [2][3][4] -a concept that conflicts with the thermodynamic principle of mitochondrial respiratory control 1,5,6 . As such, Lewandowski et al 1 recently proposed a revised model of β-cell fuel sensing, which we refer to here as the MitoCat-MitoOx model, that is relevant to human islets and the in vivo context 1,7 .…”
Section: Introductionmentioning
confidence: 96%
“…Following membrane depolarization, the increased workload (ATP hydrolysis) associated with Ca 2+ extrusion and exocytosis elevates ADP, which activates oxidative phosphorylation to sustain the secretory phase in a phase referred to as MitoOx. While the biochemical underpinnings of this new model are supported by many islet studies, over the course of decades [1][2][3][4] , the current lack of genetic evidence supporting the roles of PK and PCK2 in compartmentalized KATP closure may preclude its wide acceptance.…”
Section: Introductionmentioning
confidence: 99%
“…Insulin release is stimulated by the metabolism-dependent closure of ATPsensitive K + (KATP) channels (Ashcroft et al, 1984;Cook and Hales, 1984;Rorsman and Trube, 1985), which triggers Ca 2+ influx and exocytosis (Anderson and Long, 1947;Grodsky et al, 1963). Contrary to what is often believed, the glucose-induced signaling process in β-cells has not been largely solved, and the entrenched model (Campbell and Newgard, 2021;Prentki et al, 2013;Thompson and Satin, 2021) implicating a rise in mitochondrially-derived ATP driving KATP channel closure is likely wrong, the main reason being that it does not account for the thermodynamic principle of mitochondrial respiratory control (Corkey, 2020;Lewandowski et al, 2020;Nicholls, 2016). The recent discovery that pyruvate kinase (PK), which converts ADP and phosphoenolpyruvate (PEP) to ATP and pyruvate, is present on the plasma membrane and sufficient to close KATP channels (Lewandowski et al, 2020), provides a potential resolution to this decades-old problem.…”
As nutrient sensors for the organism, pancreatic β-cells use metabolism as a signaling pathway to elicit insulin secretion. Phosphoenolpyruvate (PEP), the substrate for pyruvate kinase (PK), may be a critical signaling intermediate based on its ability to locally control ATP-sensitive K+ (KATP) channels on the plasma membrane. Using isoform-specific deletion, we show that constitutively-active PKm1 is sufficient for KATP closure. Yet, it is the minor but allosterically-tunable PKm2 isoform that enables glucose-dependent regulation of the KATP channel microcompartment. In contrast to glucose, PKm1 and PKm2 have non-overlapping responses to amino acids, which generate PEP via the mitochondrial PCK2 enzyme. β-cell deletion of PCK2 blocked amino acid regulation of KATP and impacted Ca2+ influx (via PKm1) and extrusion (via PKm2). Shifting the β-cell from PKm2 to PKm1 correspondingly increased secretory output. Together, these three knockout models indicate that the source of PEP and the isoforms of PK are key determinants of the β-cell nutrient response.
“…An amino acid-stimulated rise in ATP/ADP c was shown to be insufficient to close K ATP channels, ruling out a key aspect of the “canonical model” in which accelerated mitochondrial metabolism raises ATP/ADP c to close K ATP channels (Campbell and Newgard, 2021; Prentki et al, 2013; Thompson and Satin, 2021). In PKm1-deficient β-cells, amino acids increased ATP/ADP c similarly to control β-cells, but were unable to close K ATP channels.…”
Section: Discussionmentioning
confidence: 99%
“…Plasma membrane-localized pyruvate kinase (PK) plays a key role in this nutrient response by converting phosphoenolpyruvate (PEP) and ADP to pyruvate and ATP, locally raising the ATP/ADP ratio in the KATP channel microcompartment to depolarize the membrane and initiate insulin secretion 1 . This local mechanism of control obviates the "standard model" of β-cell fuel sensing in which mitochondrial oxidative phosphorylation raises the ATP/ADP ratio to close KATP channels [2][3][4] -a concept that conflicts with the thermodynamic principle of mitochondrial respiratory control 1,5,6 . As such, Lewandowski et al 1 recently proposed a revised model of β-cell fuel sensing, which we refer to here as the MitoCat-MitoOx model, that is relevant to human islets and the in vivo context 1,7 .…”
Section: Introductionmentioning
confidence: 96%
“…Following membrane depolarization, the increased workload (ATP hydrolysis) associated with Ca 2+ extrusion and exocytosis elevates ADP, which activates oxidative phosphorylation to sustain the secretory phase in a phase referred to as MitoOx. While the biochemical underpinnings of this new model are supported by many islet studies, over the course of decades [1][2][3][4] , the current lack of genetic evidence supporting the roles of PK and PCK2 in compartmentalized KATP closure may preclude its wide acceptance.…”
Section: Introductionmentioning
confidence: 99%
“…Insulin release is stimulated by the metabolism-dependent closure of ATPsensitive K + (KATP) channels (Ashcroft et al, 1984;Cook and Hales, 1984;Rorsman and Trube, 1985), which triggers Ca 2+ influx and exocytosis (Anderson and Long, 1947;Grodsky et al, 1963). Contrary to what is often believed, the glucose-induced signaling process in β-cells has not been largely solved, and the entrenched model (Campbell and Newgard, 2021;Prentki et al, 2013;Thompson and Satin, 2021) implicating a rise in mitochondrially-derived ATP driving KATP channel closure is likely wrong, the main reason being that it does not account for the thermodynamic principle of mitochondrial respiratory control (Corkey, 2020;Lewandowski et al, 2020;Nicholls, 2016). The recent discovery that pyruvate kinase (PK), which converts ADP and phosphoenolpyruvate (PEP) to ATP and pyruvate, is present on the plasma membrane and sufficient to close KATP channels (Lewandowski et al, 2020), provides a potential resolution to this decades-old problem.…”
As nutrient sensors for the organism, pancreatic β-cells use metabolism as a signaling pathway to elicit insulin secretion. Phosphoenolpyruvate (PEP), the substrate for pyruvate kinase (PK), may be a critical signaling intermediate based on its ability to locally control ATP-sensitive K+ (KATP) channels on the plasma membrane. Using isoform-specific deletion, we show that constitutively-active PKm1 is sufficient for KATP closure. Yet, it is the minor but allosterically-tunable PKm2 isoform that enables glucose-dependent regulation of the KATP channel microcompartment. In contrast to glucose, PKm1 and PKm2 have non-overlapping responses to amino acids, which generate PEP via the mitochondrial PCK2 enzyme. β-cell deletion of PCK2 blocked amino acid regulation of KATP and impacted Ca2+ influx (via PKm1) and extrusion (via PKm2). Shifting the β-cell from PKm2 to PKm1 correspondingly increased secretory output. Together, these three knockout models indicate that the source of PEP and the isoforms of PK are key determinants of the β-cell nutrient response.
“…The consequent increase in cytoplasmic ATP/ADP ratio inhibits ATP-sensitive potassium channels in the beta cell plasma membrane, such that plasma membrane potential declines. This in turn opens voltage-sensitive calcium channels, causing an influx of calcium that triggers increased exocytosis of beta cell insulin granules [ 7 , 8 ]. The resulting increase in plasma insulin promotes storage of the elevated plasma glucose, such that postprandial glucose eventually returns to its healthy baseline level.…”
Section: Failure Of Beta Cell Glucose-stimulated Insulin Secretion Initiates Onset Of Type 2 Diabetesmentioning
In people with metabolic syndrome, episodic exposure of pancreatic beta cells to elevated levels of both glucose and free fatty acids (FFAs)—or glucolipotoxicity—can induce a loss of glucose-stimulated insulin secretion (GSIS). This in turn can lead to a chronic state of glucolipotoxicity and a sustained loss of GSIS, ushering in type 2 diabetes. Loss of GSIS reflects a decline in beta cell glucokinase (GK) expression associated with decreased nuclear levels of the pancreatic and duodenal homeobox 1 (PDX1) factor that drives its transcription, along with that of Glut2 and insulin. Glucolipotoxicity-induced production of reactive oxygen species (ROS), stemming from both mitochondria and the NOX2 isoform of NADPH oxidase, drives an increase in c-Jun N-terminal kinase (JNK) activity that promotes nuclear export of PDX1, and impairs autocrine insulin signaling; the latter effect decreases PDX1 expression at the transcriptional level and up-regulates beta cell apoptosis. Conversely, the incretin hormone glucagon-like peptide-1 (GLP-1) promotes nuclear import of PDX1 via cAMP signaling. Nutraceuticals that quell an increase in beta cell ROS production, that amplify or mimic autocrine insulin signaling, or that boost GLP-1 production, should help to maintain GSIS and suppress beta cell apoptosis in the face of glucolipotoxicity, postponing or preventing onset of type 2 diabetes. Nutraceuticals with potential in this regard include the following: phycocyanobilin—an inhibitor of NOX2; agents promoting mitophagy and mitochondrial biogenesis, such as ferulic acid, lipoic acid, melatonin, berberine, and astaxanthin; myo-inositol and high-dose biotin, which promote phosphatidylinositol 3-kinase (PI3K)/Akt activation; and prebiotics/probiotics capable of boosting GLP-1 secretion. Complex supplements or functional foods providing a selection of these agents might be useful for diabetes prevention.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.